VIACYTE, INC.

SAN DIEGO, CA · CIK 0001581903 · Biotech · Acquired

Encapsulated human embryonic stem cell-derived beta cells in a macro-encapsulation device for insulin production

Grants
$955K
2 awards
Sector median: 1
Raised
$150M
5 Form D · Apr 2021
65 months since last filing
Contracts
—
No federal contracts on record
Patents
40
20 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$12,150,824
Private capital raisedForm D · SEC$15,000,000
Federal grantDepartment of Health and Human Services · Phase II · Treatment of type 1 diabetes with human embryonic stem cell derived pancreatic beta-like cells$500,370
Federal grantDepartment of Health and Human Services · Phase II · Treatment of type 1 diabetes with human embryonic stem cell derived pancreatic beta-like cells$454,220
Private capital raisedForm D · SEC$35,833,603
Private capital raisedForm D · SEC$32,645,780
Private capital raisedForm D · SEC$53,931,166
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2280bluebird bio—$179M
2281EFFECTORBIO, INC.——
2282Ensysce Biosciences, Inc.—$103M
2283VIACYTE, INC.—$150M
2284EMULATE THERAPEUTICS, INC.—$12M
2285Dicerna Pharmaceuticals, Inc.—$90M
2286CytoDyn Inc.—$88M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 28 related persons
  • Steven AltmanDirector
  • Brittany BradrickExecutive Officer
  • Elizabeth BuiExecutive Officer
  • Liz BuiExecutive Officer
  • Kevin D'AmourExecutive Officer
  • Donald ElmerDirector
  • Mark FolettaDirector
  • Howard FoytExecutive Officer
  • Paul HastingsDirector
  • Lucian IancoviciDirector
  • Franklin JohnsonDirector
  • Orville KoltermanDirector
  • Adam KoppelDirector
  • Steve KradjianExecutive Officer
  • Paul LaikindDirector · Executive Officer
  • Heath LukatchDirector
  • Fred MiddletonDirector
  • Sandra PooleDirector
  • Allan RobinExecutive Officer
  • Allan RobinsExecutive Officer
  • Anne SandanExecutive Officer
  • Michael ScottExecutive Officer
  • Ian SmithDirector
  • Steve WhiteExecutive Officer
  • Asish XavierDirector
  • Michael YangDirector · Executive Officer
  • Amir ZamaniDirector
  • Mark ZimmermanExecutive Officer

Patents

USPTO · 20 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.